351 related articles for article (PubMed ID: 25874161)
1. Pain in multiple system atrophy and progressive supranuclear palsy compared to Parkinson's disease.
Kass-Iliyya L; Kobylecki C; McDonald KR; Gerhard A; Silverdale MA
Brain Behav; 2015 May; 5(5):e00320. PubMed ID: 25874161
[TBL] [Abstract][Full Text] [Related]
2. Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Numao A; Suzuki K; Miyamoto M; Miyamoto T; Hirata K
Parkinsonism Relat Disord; 2014 Feb; 20(2):212-6. PubMed ID: 24280021
[TBL] [Abstract][Full Text] [Related]
3. The interrelationship between non-motor symptoms in Atypical Parkinsonism.
Lee CN; Kim M; Lee HM; Jang JW; Lee SM; Kwon DY; Park KW; Koh SB
J Neurol Sci; 2013 Apr; 327(1-2):15-21. PubMed ID: 23428208
[TBL] [Abstract][Full Text] [Related]
4. Joint and skeletal deformities in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Ashour R; Jankovic J
Mov Disord; 2006 Nov; 21(11):1856-63. PubMed ID: 16941460
[TBL] [Abstract][Full Text] [Related]
5. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
Yoshita M; Hayashi M; Hirai S
Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
[TBL] [Abstract][Full Text] [Related]
6. Comparison of autonomic dysfunction in patients with Parkinson's Disease, progressive supranuclear palsy, and multiple system atrophy.
Malkiewicz JJ; Siuda J
Neurol Neurochir Pol; 2024; 58(2):193-202. PubMed ID: 38148738
[TBL] [Abstract][Full Text] [Related]
7. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
[TBL] [Abstract][Full Text] [Related]
8. Pain processing in atypical Parkinsonisms and Parkinson disease: A comparative neurophysiological study.
Avenali M; Tassorelli C; De Icco R; Perrotta A; Serrao M; Fresia M; Pacchetti C; Sandrini G
Clin Neurophysiol; 2017 Oct; 128(10):1978-1984. PubMed ID: 28829981
[TBL] [Abstract][Full Text] [Related]
9. Speech disorders reflect differing pathophysiology in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Rusz J; Bonnet C; Klempíř J; Tykalová T; Baborová E; Novotný M; Rulseh A; Růžička E
J Neurol; 2015; 262(4):992-1001. PubMed ID: 25683763
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological functions in progressive supranuclear palsy, multiple system atrophy and Parkinson's disease.
Krishnan S; Mathuranath PS; Sarma S; Kishore A
Neurol India; 2006 Sep; 54(3):268-72. PubMed ID: 16936386
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and progression of cognitive deficits in progressive supranuclear palsy vs. multiple system atrophy and Parkinson's disease.
Fiorenzato E; Antonini A; Camparini V; Weis L; Semenza C; Biundo R
J Neural Transm (Vienna); 2019 Nov; 126(11):1437-1445. PubMed ID: 31432258
[TBL] [Abstract][Full Text] [Related]
12. Diffusion-weighted magnetic resonance imaging differentiates Parkinsonian variant of multiple-system atrophy from progressive supranuclear palsy.
Paviour DC; Thornton JS; Lees AJ; Jäger HR
Mov Disord; 2007 Jan; 22(1):68-74. PubMed ID: 17089396
[TBL] [Abstract][Full Text] [Related]
13. Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD.
Yekhlef F; Ballan G; Macia F; Delmer O; Sourgen C; Tison F
J Neural Transm (Vienna); 2003 Feb; 110(2):151-69. PubMed ID: 12589575
[TBL] [Abstract][Full Text] [Related]
14. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
Kim KJ; Jeong SJ; Kim JM
Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
[TBL] [Abstract][Full Text] [Related]
15. Brain dopamine-stimulated adenylyl cyclase activity in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
Tong J; Fitzmaurice PS; Ang LC; Furukawa Y; Guttman M; Kish SJ
Ann Neurol; 2004 Jan; 55(1):125-9. PubMed ID: 14705122
[TBL] [Abstract][Full Text] [Related]
16. Serum uric acid levels in Parkinson's disease and related disorders.
Sakuta H; Suzuki K; Miyamoto T; Miyamoto M; Numao A; Fujita H; Watanabe Y; Hirata K
Brain Behav; 2017 Jan; 7(1):e00598. PubMed ID: 28127516
[TBL] [Abstract][Full Text] [Related]
17. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Tykalova T; Rusz J; Klempir J; Cmejla R; Ruzicka E
Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of parkinsonian syndromes according to differences in executive functions.
Lange KW; Tucha O; Alders GL; Preier M; Csoti I; Merz B; Mark G; Herting B; Fornadi F; Reichmann H; Vieregge P; Reiners K; Becker G; Naumann M
J Neural Transm (Vienna); 2003 Sep; 110(9):983-95. PubMed ID: 12938023
[TBL] [Abstract][Full Text] [Related]
19. Urinary Dysfunction in Progressive Supranuclear Palsy Compared with Other Parkinsonian Disorders.
Yamamoto T; Tateno F; Sakakibara R; Furukawa S; Asahina M; Uchiyama T; Hirano S; Yamanaka Y; Fuse M; Koga Y; Yanagisawa M; Kuwabara S
PLoS One; 2016; 11(2):e0149278. PubMed ID: 26886104
[TBL] [Abstract][Full Text] [Related]
20. A Histologic Study of the Circadian System in Parkinson Disease, Multiple System Atrophy, and Progressive Supranuclear Palsy.
De Pablo-Fernández E; Courtney R; Warner TT; Holton JL
JAMA Neurol; 2018 Aug; 75(8):1008-1012. PubMed ID: 29710120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]